Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gines Escolar

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Journal of Medical Economics|March 7, 2025
Cost-effectiveness and cost-utility analysis of Haemate-P versus other von Willebrand disease treatments in SpainJuan E Megias-Vericat, Gines Escolar, Michele R Wilson, et al.
Blood Transfusion = Trasfusione Del Sangue|October 13, 2012
Impact of experimental haemodilution on platelet function, thrombin generation and clot firmness: effects of different coagulation factor concentratesCarolina Caballo, Gines Escolar, Maribel Diaz-Ricart, et al.
Bone Marrow Transplantation|January 13, 2023
Mafosfamide, a cyclophosphamide analog, causes a proinflammatory response and increased permeability on endothelial cells in vitroJulia Martinez-Sanchez, Roger Pascual-Diaz, Marta Palomo, et al.
Plos One|November 19, 2013
Reversal of apixaban induced alterations in hemostasis by different coagulation factor concentrates: significance of studies in vitro with circulating human bloodGines Escolar, Victor Fernandez-Gallego, Eduardo Arellano-Rodrigo, et al.
Atherosclerosis|January 17, 2020
Internalization of microparticles by platelets is partially mediated by toll-like receptor 4 and enhances platelet thrombogenicityDidac Jerez-Dolz, Sergi Torramade-Moix, Marta Palomo, et al.
Transfusion Medicine Reviews|September 14, 2015
Coagulation Factor Concentrates Fail to Restore Alterations in Fibrin Formation Caused by Rivaroxaban or Dabigatran in Studies With Flowing Blood From Treated Healthy VolunteersEduardo Arellano-Rodrigo, Irene Lopez-Vilchez, Ana M Galan, et al.
Thrombosis and Haemostasis|December 7, 2017
Escitalopram Impairs Thrombin-Induced Platelet Response, Cytoskeletal Assembly and Activation of Associated Signalling PathwaysIrene Lopez-Vilchez, Didac Jerez-Dolz, Maribel Diaz-Ricart, et al.
Science Advances|June 18, 2019
Targeting thrombogenicity and inflammation in chronic HIV infectionMeagan P O'Brien, M Urooj Zafar, Jose C Rodriguez, et al.
Thrombosis and Haemostasis|August 25, 2017
Antithrombotic potency of ticagrelor versus clopidogrel in type-2 diabetic patients with cardiovascular diseaseM Urooj Zafar, Usman Baber, Donald A Smith, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 9, 2014
Reversal of rivaroxaban-induced alterations on hemostasis by different coagulation factor concentrates – in vitro studies with steady and circulating human bloodGines Escolar, Eduardo Arellano-Rodrigo, Irene Lopez-Vilchez, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Journal of Medical Economics|March 7, 2025
Cost-effectiveness and cost-utility analysis of Haemate-P versus other von Willebrand disease treatments in SpainJuan E Megias-Vericat, Gines Escolar, Michele R Wilson, et al.
Blood Transfusion = Trasfusione Del Sangue|October 13, 2012
Impact of experimental haemodilution on platelet function, thrombin generation and clot firmness: effects of different coagulation factor concentratesCarolina Caballo, Gines Escolar, Maribel Diaz-Ricart, et al.
Bone Marrow Transplantation|January 13, 2023
Mafosfamide, a cyclophosphamide analog, causes a proinflammatory response and increased permeability on endothelial cells in vitroJulia Martinez-Sanchez, Roger Pascual-Diaz, Marta Palomo, et al.
Plos One|November 19, 2013
Reversal of apixaban induced alterations in hemostasis by different coagulation factor concentrates: significance of studies in vitro with circulating human bloodGines Escolar, Victor Fernandez-Gallego, Eduardo Arellano-Rodrigo, et al.
Atherosclerosis|January 17, 2020
Internalization of microparticles by platelets is partially mediated by toll-like receptor 4 and enhances platelet thrombogenicityDidac Jerez-Dolz, Sergi Torramade-Moix, Marta Palomo, et al.
Transfusion Medicine Reviews|September 14, 2015
Coagulation Factor Concentrates Fail to Restore Alterations in Fibrin Formation Caused by Rivaroxaban or Dabigatran in Studies With Flowing Blood From Treated Healthy VolunteersEduardo Arellano-Rodrigo, Irene Lopez-Vilchez, Ana M Galan, et al.
Thrombosis and Haemostasis|December 7, 2017
Escitalopram Impairs Thrombin-Induced Platelet Response, Cytoskeletal Assembly and Activation of Associated Signalling PathwaysIrene Lopez-Vilchez, Didac Jerez-Dolz, Maribel Diaz-Ricart, et al.
Science Advances|June 18, 2019
Targeting thrombogenicity and inflammation in chronic HIV infectionMeagan P O'Brien, M Urooj Zafar, Jose C Rodriguez, et al.
Thrombosis and Haemostasis|August 25, 2017
Antithrombotic potency of ticagrelor versus clopidogrel in type-2 diabetic patients with cardiovascular diseaseM Urooj Zafar, Usman Baber, Donald A Smith, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 9, 2014
Reversal of rivaroxaban-induced alterations on hemostasis by different coagulation factor concentrates – in vitro studies with steady and circulating human bloodGines Escolar, Eduardo Arellano-Rodrigo, Irene Lopez-Vilchez, et al.
Pageof 8